Table 3.
Group | N | IL-23 (pg/ml) | IL-10 (pg/ml) | INF-γ (pg/ml) | TGF-β (ng/ml) |
---|---|---|---|---|---|
Healthy control | 20 | 87.67±7.35 | 0.66±0.09 | 314.34±40.06 | 395.68±30.57 |
Early stage | 5 | 68.94±10.58**,## | 0.68±0.05## | 216.35±18.45**,## | 474.48±35.78**,## |
Progression stage | 15 | 41.81±0.15** | 1.01±0.05** | 166.45±5.38** | 515.57±21.89** |
Advanced stage | 20 | 21.86±0.12**,## | 1.28±0.22**,## | 129.01±4.17**,## | 631.45±36.66**,## |
P<0.01 compared with healthy control;
P<0.01 compared with progression stage group.